Bellesi, Silvia
 Distribuzione geografica
Continente #
EU - Europa 2.505
NA - Nord America 2.269
AS - Asia 811
AF - Africa 27
SA - Sud America 11
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.629
Nazione #
US - Stati Uniti d'America 2.229
DE - Germania 835
SE - Svezia 455
IT - Italia 364
CN - Cina 343
SG - Singapore 234
PL - Polonia 179
FR - Francia 141
GB - Regno Unito 123
UA - Ucraina 116
IE - Irlanda 105
ID - Indonesia 72
IN - India 55
FI - Finlandia 50
RU - Federazione Russa 50
CA - Canada 40
CI - Costa d'Avorio 21
JP - Giappone 21
TW - Taiwan 21
CZ - Repubblica Ceca 18
TR - Turchia 18
BE - Belgio 17
IR - Iran 11
HK - Hong Kong 8
ES - Italia 7
LT - Lituania 7
AT - Austria 6
KR - Corea 6
BR - Brasile 5
MY - Malesia 5
PT - Portogallo 5
AU - Australia 4
CH - Svizzera 4
GR - Grecia 4
IL - Israele 4
RO - Romania 4
VN - Vietnam 4
CL - Cile 3
CO - Colombia 3
NO - Norvegia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
HU - Ungheria 2
NL - Olanda 2
RS - Serbia 2
TH - Thailandia 2
BG - Bulgaria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
IQ - Iraq 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 5.629
Città #
Chandler 482
Ashburn 189
Warsaw 178
Singapore 177
Fairfield 116
Dublin 104
Jacksonville 90
San Mateo 81
Houston 76
Jakarta 71
New York 71
Rome 71
Nanjing 64
Wilmington 64
Beijing 62
Dearborn 60
Ann Arbor 58
Woodbridge 53
Nürnberg 50
Seattle 49
Marseille 46
Moscow 43
Milan 40
Munich 40
Boston 38
Bremen 37
Cattolica 37
Princeton 34
Lancaster 31
Nanchang 29
Redwood City 24
Abidjan 21
Los Angeles 21
Cambridge 20
Helsinki 20
Lawrence 20
Boardman 18
Chicago 18
London 18
Brno 17
Hangzhou 17
Leawood 16
Brussels 15
Guangzhou 14
Toronto 14
Fremont 12
Tianjin 12
Changsha 11
Hefei 11
Izmir 11
Norwalk 10
Shanghai 10
Florence 9
Kunming 9
Kyoto 9
Auburn Hills 8
Hebei 8
Pune 8
Redmond 8
Augusta 7
Lappeenranta 7
San Diego 7
Santa Clara 7
Washington 7
Zhengzhou 7
Enterprise 6
Hong Kong 6
Jiaxing 6
Kish 6
Mountain View 6
Phoenix 6
Romainville 6
Shenyang 6
Andover 5
Bologna 5
Hyderabad 5
Ottawa 5
Philadelphia 5
San Francisco 5
Seoul 5
University Park 5
Arezzo 4
Busto Arsizio 4
Falls Church 4
Kocaeli 4
Kuala Lumpur 4
Livorno 4
Nuremberg 4
São Paulo 4
Bogotá 3
Changchun 3
Dong Ket 3
Lanzhou 3
Mumbai 3
Paris 3
Quzhou 3
Shenzhen 3
Tokyo 3
Asti 2
Baltimore 2
Totale 3.143
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 355
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 285
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 267
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 205
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 171
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 171
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 168
Correlation between paraproteinaemia and viral reactivation after allo-SCT 142
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 138
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 133
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 128
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 127
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 124
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 121
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 102
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 101
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 101
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 100
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 100
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 98
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 96
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 88
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 86
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 86
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 84
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 84
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 79
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 79
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 76
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 74
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 70
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 69
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 67
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 67
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 66
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 65
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 64
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 63
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 61
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 61
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 60
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 57
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 56
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 55
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 51
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 49
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 47
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 44
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 43
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 39
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 38
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 31
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 30
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 29
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 29
External validation of the accuracy of 'CLLflow score' 28
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 20
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 19
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 19
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 17
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 15
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 14
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 13
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 13
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 12
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 12
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 10
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 10
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 9
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 9
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 8
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 7
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 7
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 6
Totale 5.770
Categoria #
all - tutte 23.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020551 0 0 0 0 70 84 70 51 68 69 96 43
2020/2021611 33 44 36 50 71 53 41 26 44 42 143 28
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024738 33 181 28 41 26 100 54 54 10 29 86 96
2024/2025496 65 61 118 101 151 0 0 0 0 0 0 0
Totale 5.770